helps life science companies navigate the complex commercialization and market access landscape. We empower companies to develop definitive strategies and achieve commercial success.
We believe every person
deserves to live life to the
fullest with access to
transformative therapies.
Definitive Health Partners
helps life science companies
turn this vision into reality.
ABOUT
BE
DEFINITIVE.
Why work with us?
The commercialization and market access landscapes are complex and always evolving. Definitive Health Partners helps life science companies navigate this complexity and deliver precise, bold, and effective strategy to achieve commercial goals.
Our team consists of biopharmaceutical industry veterans with expertise across the entire commercialization spectrum. Our real-world experience enables us to develop tailored solutions that best fit your unique needs.
Expertise
Our decades of experience leading
rare disease and specialty biopharmaceutical brands across the entire product life cycle gives your teams the confidence needed to ensure commercial success.
Partnership
Transparency and accountability are our guiding principles. We become an extension of your team so you can count on us for delivering the solutions you need when you need them.
Results
Our leadership team is actively involved to ensure each project receives the level of expertise required for high-quality results and timely delivery. Our unique approach allows your team to exceed expectations and achieve outstanding client satisfaction.
SOLUTIONS
PRECISE, BOLD, EFFECTIVE SOLUTIONS
TAILORED TO YOUR NEEDS
Definitive Health Partners offers a comprehensive suite of commercialization and market access solutions to help your transformative therapy achieve its commercial goals.
We partner with life science companies to develop precise strategies with bold pull-through tactics. We solve each challenge with tailored solutions that match your commercial goals and vision. We enhance your team with in-depth knowledge and skills for flawless implementation.
End-to-End
Market Access Solutions
Definitive Health Partners helps transformative therapies obtain optimal and timely access and reimbursement through a customized approach at each customer touch point.
Strategy
Planning
Access &
Reimbursement
Payer Research
& Insight
Cost, Coding and
Coverage
Patient
Services
Claims
Data Analysis
Training &
Education
Distribution
Optimization
CMS
Policy
Pricing &
Contracting
Marketing &
Account
Resources
Patient
Advocacy
Proof-of-Concept to Post-Launch
Marketing Strategy
The commercial landscape is constantly evolving with emerging diseases, changing customer dynamic, and new products and technology. Definitive Health Partners helps you navigate this ever-changing environment by providing clear and effective solutions starting from product conception to post-launch.
Our comprehensive process helps you develop strategies and tactics starting from the early stage of product development all the way to post-launch. We help companies build and enhance launch plans to establish commercial excellence and ensure ongoing success.
Uncovering
Market
Insights
-
Market sizing & assessment
-
Disease awareness
-
Market opportunity assessment
-
Decision-support modeling and quantitative analytics
-
Competitive analysis
Translating
Insights into
Actionable Strategies
-
Market shaping strategy
-
Launch strategy and planning
-
Learning & Development
-
Scenario planning
-
Competitive gaming
Delivering Product
Commercialization Success
-
Managed markets performance diagnostic
-
Unbranded & branded campaigns
-
Account segmentation
-
Tool development
-
Operational excellence
Driving Growth
of In-line
Products
-
Brand planning and strategy development
-
Life cycle planning
-
Loss-of-exclusivity planning
-
Competitive assessments/ Counter-Launch
How We’re Different
Understanding your customers in real time is vital. Definitive Health Partners offers a wide range of customizable market insights and solutions that can be integrated into your strategy development.
Senior leadership involvement throughout the process allows us to leverage our commercial DNA to translate insights into actionable strategies & tactics.
Research +
Gains stakeholder feedback to address specific needs and challenges, while also leveraging industry insights to inform decision-making.
Insights =
Insights are a deep understanding gained through analysis of data, research findings, and market research to gain a competitive edge.
Solutions
Solutions resolve issues by creating a specific course of action that considers long-term consequences and drives successful outcomes.
Professional Execution
•Research is designed and executed by senior leadership with deep commercial experience
•Proprietary reverse-engineering methodology (RIM) designed to uncover unique insights
•Results are analyzed by the same leadership team dedicated, professional staff
Deep Reach & Relationships
•HCPs & patient panels
•Payer panels representing Commercial, Medicare, and Medicaid lives
•Advisors are vetted for experience, candor, and reliability
•Recruitment into multiple sites of care (hospitals, pharmacies, IDNs, clinics, LTC, etc.)
Research
Primary
Research
•Primary quantitative research is conducted with payers, physicians, patients, and caregivers
•Custom studies focused on value creation:
Target product profile testing, Attitude and Usage, segmentation, positioning, product tracking, price
elasticity, etc.
Secondary
Research
•Definitive utilizes proprietary database of market research
•Systemic investigation allows for defining gaps and market insights
•Internal staff reviews competitive data to provide a cohesive roadmap and benchmarking
Interactive
Engagement
•Advisory boards and workshops
•Payer panels
•Offsite payer workshops
•Virtual advisory panels and focus groups
Claims/Data
Analytics
•Access to CMS and commercial data
•Analyses can include overall market size, demographics, coverage and reimbursement, and patient journey
Insights and Solutions
Discover what key insights lead to successful solutions.
Insight
Payer research revealed need for more in-depth product clinical information and data to enhance product differentiation
Solution
Development of unique value proposition and payer messaging focused on the product’s targeted mechanism of action
Insight
Provider research uncovered multiple deficiencies of current Hub provider
Solution
Formulation of Patient Services Refinement Plan, RFP Creation, and HUB Negotiation Assistance
Insight
KOL research revealed several gaps/inconsistencies in overall understanding of how both the patient and product journeys interact and impact each other
Solution
Development of a dynamic patient/product journey that uncovered unique ways to fill current gaps that enhanced patient outcomes
Insight
Claims analysis showed that providers were switching patients to a competitive product based on patient OOP costs
Solution
Analysis showing the impact of co-pay maximizers and accumulators on patient OOP liability and creation of internal assistance plan to minimize impact
Insight
CMS coverage and coding research showed that many providers were using a miscellaneous code for a reformulated product
Solution
Creation of company CMS policy and HCPCS application to establish a unique HCPCS code
Insight
Pricing and contracting research revealed potential for targeted stakeholder contracting
Solution
Creation of robust, stakeholder specific, pricing, and contracting guidelines
LEADERSHIP TEAM
DIVERSE BACKGROUNDS
REAL-WORLD BIOPHARMA EXPERTISE
Our team is comprised of biopharmaceutical industry veterans with 100+ years of combined experience in commercialization and market access. Each team member brings unique expertise with stellar track records in achieving commercial success across various diseases and therapeutic areas.
Pedro Salomao
Founder and CEO
Pedro guides clients in developing Global, Market Access, Marketing, and Sales planning and execution strategies that address the rising challenges amidst the uncertain, complex, and evolving health care environment.
Pedro is a firm believer that patient-centric care is at the center of all great client engagements and should guide key elements of a successful commercial strategy. He draws from his 20+ years of real-world biopharmaceutical experience to ensure clients develop bold strategies and drive operational and tactical excellence. Before founding Definitive Health Partners, Pedro held leadership roles at various life science companies such as Boehringer Ingelheim, The Medicines Company, Baxter, Baxalta, and Shire where he led multiple orphan, biologic and specialty product launches.
Pedro has a BS in Cardiopulmonary Sciences from Northeastern University and an MBA in Marketing and Finance from Fordham University.
Michael Bradley
VP, Market Access
Michael Bradley ensures that life science companies strive to make access an integral part of all business planning. He advances and coordinates commercialization strategies that result in positive impact on patients, payers, customers, community, and companies.
Michael is an accomplished, creative, and innovative market access and commercialization launch leader with a focus on rare and ultra-rare diseases. Michael has decades of biopharmaceutical experience in value creation, pricing strategy, government policy, advocacy partnerships, HEOR, managed care, reimbursement, and patient support programs. During his nearly 25-year career at Baxter, Michael was an integral part of various launch teams with a successful track record in launching and securing access for biologic products in competitive markets.
Michael earned his BS in Biology and his MBA from California State University.
Sean Jeffries
Principal
Bringing more than two decades of dynamic leadership and strategic expertise in the life sciences sector, Sean stands as a seasoned executive with a wealth of experience in market access, specialty distribution, payer relations, and contracting. Sean demonstrates exceptional proficiency in collaborating with companies to tackle unmet needs in commercial and launch efforts through well-defined market access initiatives and strategies spanning the entire product lifecycle.
Sean has a Bachelor of Science in Pre-Med Biology from Washington State University and a dual Masters of Business Administration/Masters of Health Services Administration from Arizona State University.
CONNECT